Separately, ValuEngine upgraded shares of Rewalk Robotics from a sell rating to a hold rating in a research report on Wednesday, May 2nd. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and four have given a buy rating to the company. The stock presently has a consensus rating of Hold and a consensus target price of $2.42.
Shares of RWLK opened at $1.04 on Friday. Rewalk Robotics has a 1-year low of $0.70 and a 1-year high of $2.00. The stock has a market cap of $36.98 million, a price-to-earnings ratio of -1.05 and a beta of 0.51. The company has a quick ratio of 1.10, a current ratio of 1.37 and a debt-to-equity ratio of -5.27.
About Rewalk Robotics
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes exoskeletons for wheelchair-bound individuals with mobility impairments or other medical conditions. The company offers ReWalk Personal for everyday use to paraplegic individuals at home and in their communities; and ReWalk Rehabilitation for exercise and therapy used in hospitals and rehabilitation centers in the United States and Europe.
Featured Story: Penny Stocks
Receive News & Ratings for Rewalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rewalk Robotics and related companies with MarketBeat.com's FREE daily email newsletter.